Her2-normal

2 clinical trials · Condition

Record	Firm	Date
A Study of Palbociclib in Addition to Standard Endocrine Treatment in Hormone Receptor Positive Her2 Normal Patients With Residual Disease After Neoadjuvant Chemotherapy and Surgery (NCT01864746)	GBG Forschungs GmbH	2013-10-30
Dose Dense Doxorubucin and Cyclophosphamide Followed by Eribulin Mesylate for the Adjuvant Treatment of Early Stage Breast Cancer (NCT01328249)	Eisai Inc.	2011-03-03

Every clearance here is in the API, with alerts when new ones post.